Validation of the European Association for the Study of the Liver algorithm for the noninvasive diagnosis of advanced fibrosis in metabolic-dysfunction associated steatotic liver disease

被引：0
|
作者：
Kalligeros, Markos [1 ]
Tsochatzis, Emmanuel A. [2 ,3 ,4 ,5 ]
机构：
[1] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Div Internal Med, Providence, RI USA
[2] Royal Free Hosp, UCL Inst Liver & Digest Hlth, London, England
[3] UCL, London, England
[4] Royal Free Hosp, Sheila Sherlock Liver Unit, London, England
[5] Royal Free Hosp, Sheila Sherlock Liver Unit, Pond St, London NW3 2QG, England
来源：
HEPATOBILIARY SURGERY AND NUTRITION | 2024年 / 13卷 / 02期
关键词：
Fibroscan; enhanced liver fibrosis (ELF); fibrosis-4 (FIB-4); cirrhosis; metabolic-dysfunction associated steatotic liver disease (MASLD); METASTATIC COLORECTAL-CANCER; SIDED COLON-CANCER;
D O I：
10.21037/hbsn-23-654
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：311 / 313
页数：3
相关论文
共 50 条
  • [1] Association of metabolic-dysfunction associated steatotic liver disease with polycystic ovary syndrome
    Xu, Qiuyu
    Zhang, Jie
    Lu, Yan
    Wu, Ling
    ISCIENCE, 2024, 27 (02)
  • [2] Dietary and pharmacological treatment in patients with metabolic-dysfunction associated steatotic liver disease
    Armandi, Angelo
    Bugianesi, Elisabetta
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 122 : 20 - 27
  • [3] Apolipoprotein C-III in association with metabolic-dysfunction associated steatotic liver disease: A large, multicenter study
    Kouvari, Matina
    Valenzuela-Vallejo, Laura
    Guatibonza-Garcia, Valentina
    Verrastro, Ornella
    Axarloglou, Evangelos
    Mylonakis, Sophia C.
    George, Jacob
    Papatheodoridis, Georgios
    Mingrone, Geltrude
    Mantzoros, Christos S.
    CLINICAL NUTRITION, 2024, 43 (12) : 101 - 108
  • [4] SCREENING FOR METABOLIC-DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE AND ADVANCED FIBROSIS AMONG PATIENTS WITH OBESITY: A COST-EFFECTIVENESS ANALYSIS
    Mohanty, Arpan
    Wang, Yin
    Stoecker, Charles
    GASTROENTEROLOGY, 2024, 166 (05) : S1667 - S1667
  • [5] Impact of sexual dimorphism on liver damage in patients with metabolic-dysfunction associated steatotic liver disease
    Dileo, E.
    Rosso, C.
    Parasiliti-Caprino, M.
    Caviglia, G. P.
    Ponzetto, F.
    Leoni, L.
    Pennisi, G.
    Armandi, A.
    Guariglia, M.
    Saba, F.
    Maccario, M.
    Petta, S.
    Mengozzi, G.
    Bugianesi, E.
    DIGESTIVE AND LIVER DISEASE, 2025, 57
  • [6] Noninvasive tests to identify liver fibrosis in metabolic dysfunction-associated steatotic liver disease are affected by race
    Bril, Fernando
    Gray, Meagan
    OBESITY, 2024, 32 (03) : 612 - 622
  • [7] The importance of age for liver-related mortality in patients with metabolic-dysfunction associated steatotic liver disease
    Bjornsson, Einar S.
    HEPATOBILIARY SURGERY AND NUTRITION, 2024, 13 (01) : 124 - 127
  • [8] Advanced Liver Fibrosis Impairs Cardiorespiratory Fitness in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease
    Sogbe, Miguel
    Hummer, Breianna
    Stine, Jonathan G.
    Lizaola-Mayo, Blanca
    Forman, Daniel E.
    Vargas, Hugo E.
    Duarte-Rojo, Andres
    DIGESTIVE DISEASES AND SCIENCES, 2025, : 1530 - 1539
  • [9] Liver Cell Mitophagy in Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver Fibrosis
    Chen, Jiaxin
    Jian, Linge
    Guo, Yangkun
    Tang, Chengwei
    Huang, Zhiyin
    Gao, Jinhang
    ANTIOXIDANTS, 2024, 13 (06)
  • [10] METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE IS ASSOCIATED WITH LIVER FIBROSIS IN HEPATITIS C
    Elgretli, Wesal
    Shengir, Mohamed
    Sasson, Solomon
    Agnihotram, V. Ramanakumar
    Ballesteros, Luz Esther Ramos
    Deschenes, Marc
    Wong, Philip
    Chen, Tianyan
    Kronfli, Nadine
    Keeshan, Alexa
    Tandon, Saniya
    Cooper, Curtis
    Sebastiani, Giada
    HEPATOLOGY, 2024, 80 : S382 - S383
12345